BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Deng YH, Pu CL, Li YC, Zhu J, Xiang C, Zhang MM, Guo CB. Analysis of biliary epithelial-mesenchymal transition in portal tract fibrogenesis in biliary atresia. Dig Dis Sci. 2011;56:731-740. [PMID: 20725787 DOI: 10.1007/s10620-010-1347-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Dong R, Zheng S. Interleukin-8: A critical chemokine in biliary atresia: Interleukin-8 in biliary atresia. J Gastroenterol Hepatol 2015;30:970-6. [DOI: 10.1111/jgh.12900] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 3.9] [Reference Citation Analysis]
2 Li R, Dong J, Bu X, Huang Y, Yang J, Dong X, Liu J. Retracted : Interleukin‐6 promotes the migration and cellular senescence and inhibits apoptosis of human intrahepatic biliary epithelial cells. J Cell Biochem 2018;119:2135-43. [DOI: 10.1002/jcb.26375] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
3 Li L, Wu T, Huang J, Ma K, Xu L, Wang H, Fan X, Tao R, Ai G, Ning Q. Expression of heat shock protein 47, transforming growth factor-beta 1, and connective tissue growth factor in liver tissue of patients with Schistosoma japonicum-induced hepatic fibrosis. Parasitology. 2015;142:341-351. [PMID: 25111595 DOI: 10.1017/s0031182014001115] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
4 Godbole N, Nyholm I, Hukkinen M, Davidson JR, Tyraskis A, Eloranta K, Andersson N, Lohi J, Heikkilä P, Kyrönlahti A, Pihlajoki M, Davenport M, Heikinheimo M, Pakarinen MP. Prognostic and Pathophysiologic Significance of IL-8 (CXCL8) in Biliary Atresia. J Clin Med 2021;10:2705. [PMID: 34207442 DOI: 10.3390/jcm10122705] [Reference Citation Analysis]
5 Xu J, Liu X, Koyama Y, Wang P, Lan T, Kim IG, Kim IH, Ma HY, Kisseleva T. The types of hepatic myofibroblasts contributing to liver fibrosis of different etiologies. Front Pharmacol 2014;5:167. [PMID: 25100997 DOI: 10.3389/fphar.2014.00167] [Cited by in Crossref: 52] [Cited by in F6Publishing: 53] [Article Influence: 6.5] [Reference Citation Analysis]
6 Sung R, Lee SH, Ji M, Han JH, Kang MH, Kim JH, Choi JW, Kim YC, Park SM. Epithelial-mesenchymal transition-related protein expression in biliary epithelial cells associated with hepatolithiasis. J Gastroenterol Hepatol. 2014;29:395-402. [PMID: 23927024 DOI: 10.1111/jgh.12349] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
7 Xiao Y, Zhou Y, Chen Y, Zhou K, Wen J, Wang Y, Wang J, Cai W. The expression of epithelial-mesenchymal transition-related proteins in biliary epithelial cells is associated with liver fibrosis in biliary atresia. Pediatr Res. 2015;77:310-315. [PMID: 25406900 DOI: 10.1038/pr.2014.181] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
8 Mansfield JR. Multispectral Imaging: A Review of Its Technical Aspects and Applications in Anatomic Pathology. Vet Pathol 2014;51:185-210. [DOI: 10.1177/0300985813506918] [Cited by in Crossref: 37] [Cited by in F6Publishing: 26] [Article Influence: 4.1] [Reference Citation Analysis]
9 Tang S, Jiang X, Wu L, Chen S, Chen L, Jiang J, Yan P, Wang F, Tu K, Wang D, Gu J, Zhao L. Toll-like receptor 4 shRNA attenuates lipopolysaccharide-induced epithelial-mesenchymal transition of intrahepatic biliary epithelial cells in rats. Biomed Pharmacother 2018;107:1210-7. [PMID: 30257335 DOI: 10.1016/j.biopha.2018.08.071] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
10 Shen WJ, Chen G, Wang M, Zheng S. Liver fibrosis in biliary atresia. World J Pediatr 2019;15:117-23. [PMID: 30465125 DOI: 10.1007/s12519-018-0203-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
11 Wang ZM, Chen YJ. Recent progress in understanding pathogenesis and liver pathology in biliary atresia. Shijie Huaren Xiaohua Zazhi 2012; 20(27): 2576-2582 [DOI: 10.11569/wcjd.v20.i27.2576] [Reference Citation Analysis]
12 Zhang RZ, Zeng XH, Lin ZF, Ming-Fu, Tong YL, Lui VC, Tam PK, Lamb JR, Xia HM, Chen Y. Downregulation of Hes1 expression in experimental biliary atresia and its effects on bile duct structure. World J Gastroenterol 2018; 24(29): 3260-3272 [PMID: 30090006 DOI: 10.3748/wjg.v24.i29.3260] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Burns J, Davenport M. Adjuvant treatments for biliary atresia. Transl Pediatr 2020;9:253-65. [PMID: 32775244 DOI: 10.21037/tp.2016.10.08] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
14 Cruz-solbes AS, Youker K. Epithelial to Mesenchymal Transition (EMT) and Endothelial to Mesenchymal Transition (EndMT): Role and Implications in Kidney Fibrosis. In: Miller RK, editor. Kidney Development and Disease. Cham: Springer International Publishing; 2017. pp. 345-72. [DOI: 10.1007/978-3-319-51436-9_13] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 10.2] [Reference Citation Analysis]
15 Li M, Luan F, Zhao Y, Hao H, Zhou Y, Han W, Fu X. Epithelial-mesenchymal transition: An emerging target in tissue fibrosis. Exp Biol Med (Maywood) 2016;241:1-13. [PMID: 26361988 DOI: 10.1177/1535370215597194] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 6.7] [Reference Citation Analysis]
16 Yu K, Li Q, Shi G, Li N. Involvement of epithelial-mesenchymal transition in liver fibrosis. Saudi J Gastroenterol 2018;24:5-11. [PMID: 29451178 DOI: 10.4103/sjg.SJG_297_17] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
17 Zhao YL, Zhu RT, Sun YL. Epithelial-mesenchymal transition in liver fibrosis. Biomed Rep 2016;4:269-74. [PMID: 26998262 DOI: 10.3892/br.2016.578] [Cited by in Crossref: 51] [Cited by in F6Publishing: 52] [Article Influence: 8.5] [Reference Citation Analysis]
18 Park SM. The crucial role of cholangiocytes in cholangiopathies. Gut Liver. 2012;6:295-304. [PMID: 22844556 DOI: 10.5009/gnl.2012.6.3.295] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
19 Dong R, Deng P, Huang Y, Shen C, Xue P, Zheng S. Identification of HSP90 as potential biomarker of biliary atresia using two-dimensional electrophoresis and mass spectrometry. PLoS One 2013;8:e68602. [PMID: 23874684 DOI: 10.1371/journal.pone.0068602] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
20 Jin L, Ji S, Sun A. Efficient generation of biliary epithelial cells from rabbit intrahepatic bile duct by Y-27632 and Matrigel. In Vitro Cell Dev Biol Anim 2013;49:433-9. [PMID: 23670599 DOI: 10.1007/s11626-013-9627-z] [Reference Citation Analysis]
21 Fabris L, Brivio S, Cadamuro M, Strazzabosco M. Revisiting Epithelial-to-Mesenchymal Transition in Liver Fibrosis: Clues for a Better Understanding of the "Reactive" Biliary Epithelial Phenotype. Stem Cells Int 2016;2016:2953727. [PMID: 26880950 DOI: 10.1155/2016/2953727] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
22 Zhou YN, Mu YP, Liu P. Sources of myofibroblasts in liver fibrosis. Shijie Huaren Xiaohua Zazhi 2013; 21(31): 3376-3382 [DOI: 10.11569/wcjd.v21.i31.3376] [Reference Citation Analysis]